Furthermore, certain medications, particularly antidepressants and hormone therapies, can also trigger night sweats, making it essential for individuals to discuss their symptoms with healthcare providers to identify potential causes and appropriate treatments
over whether they may increase the risk for CV problems," said Marc Pfeffer of Harvard Medical School and Brigham and Women's Hospital in the US, who presented the results of the ELIXA trial of Sanofi's glucagon-like peptide-1 (GLP-1) agonist Lyxumia (lixisenatide) at the ADA
Research Overview Current research interest around Retatrutide centres on its potential multi-receptor activity and its role within experimental metabolic models
During your consultation, your provider will review your health history and recommend the treatment that best meets your individual needs
A recent study showed people who stop taking GLP-1 jabs regain all the weight they lost in under two years
Does bariatric surgery increase GLP-1 levels